| Title |
Quality of Reporting of Bioequivalence Trials Comparing Generic to Brand Name Drugs: A Methodological Systematic Review
|
|---|---|
| Published in |
PLOS ONE, August 2011
|
| DOI | 10.1371/journal.pone.0023611 |
| Pubmed ID | |
| Authors |
Amélie van der Meersch, Agnès Dechartres, Philippe Ravaud |
| Abstract |
Generic drugs are used by millions of patients for economic reasons, so their evaluation must be highly transparent. |
X Demographics
The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Greece | 2 | 22% |
| Curaçao | 1 | 11% |
| Unknown | 6 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 8 | 89% |
| Practitioners (doctors, other healthcare professionals) | 1 | 11% |
Mendeley readers
The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 4% |
| India | 1 | 2% |
| Unknown | 54 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 9 | 16% |
| Student > Master | 8 | 14% |
| Student > Bachelor | 8 | 14% |
| Other | 6 | 11% |
| Professor | 4 | 7% |
| Other | 16 | 28% |
| Unknown | 6 | 11% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 27 | 47% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 11% |
| Agricultural and Biological Sciences | 6 | 11% |
| Social Sciences | 2 | 4% |
| Business, Management and Accounting | 1 | 2% |
| Other | 5 | 9% |
| Unknown | 10 | 18% |